SNY

Recent Articles

Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma

Sanofi has a rough time during 2016, but after the U.S. presidential election and with several forward-looking decisions, SNY stock is a buy. More 

Regeneron Pharmaceuticals Inc (REGN) Stock Pops on Mixed Q3 Results

Regeneron Pharmaceuticals Inc (REGN) stock was up on Friday following mixed results in its earnings report for the third quarter of 2016. More 

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there. More 

Sanofi SA (ADR) (SNY) Sues Merck & Co., Inc. (MRK) Over Multiple Patent Infringements

Sanofi (SNY) is suing Merck (MRK) for what it claims are several instances of patent infringement connected to its diabetes drug Lantus. More 

6 More Pharma Companies Selling Overpriced Drugs

Overpriced drugs are more common with the pharma industry than most realize, and these names are the worst offenders. More 

12 Pharmaceuticals Stocks to Sell Now

This week, the overall grades of 12 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Warren Buffett’s 3 Best Dividend Stocks (VZ, SNY, GM)

In today's difficult long-term investing environment, Warren Buffett dividend stocks VZ, SNY and GM may be the best ideas in the market. More